Gurdaspur, Abrol Hospital, a Unit of EMC Group
Human Metapneumovirus (HMPV) is a significant respiratory pathogen first identified in 2001. It primarily causes acute respiratory infections in children under five, the elderly, and individuals with weakened immune systems. Common symptoms include fever, cough, sore throat, and nasal congestion. In severe cases, it can lead to pneumonia and other respiratory complications.
The diagnosis of HMPV is done through RT-PCR (the gold standard) and rapid antigen detection. However, there is no specific antiviral treatment available for HMPV. Management focuses on supportive care, such as oxygen supplementation and symptom-based therapy.
A sharp rise in respiratory infections has been observed since December 2024, with HMPV contributing to the cases. Experts note that while HMPV is a concern, it is unlikely to cause a pandemic like COVID-19 due to the presence of natural immunity against this virus in most individuals.
Expert Insights:
Dr. Amarnath, a senior physician at Abrol Hospital, emphasized, “Do not ignore respiratory infections like HMPV. Timely treatment can prevent severe complications.”
Dr. Rishabh Arora, Director of Abrol Hospital, stated in his message, “Health is the greatest wealth. If you experience any respiratory symptoms, consult a specialist immediately. Abrol Hospital, a unit of EMC Group, is dedicated to providing the best care for you and your family.”
About Abrol Hospital:
Located in Gurdaspur, Abrol Hospital is a trusted unit of the EMC Group, committed to the well-being of its patients and offering top-quality healthcare services.
